Signal

Beijing-based MegaRobo, which uses robotics and AI to automate lab work for biotech research, raised ~$200M; it became a unicorn after raising $300M in 2022

First reported by Bloomberg ·

The signal ●●●○ Compiled by AI from Bloomberg, Techmeme and DealStreetAsia
Why you might care

The cost of automating lab work may fall.

What happened

Beijing-based MegaRobo Technologies raised nearly $200 million from investors including Oman's sovereign wealth fund.

What it means

Based on limited preview — the full article may require a subscription

MegaRobo Technologies, a Chinese biotech company, secured nearly $200 million in funding. Investors, including Oman's sovereign wealth fund, are backing companies that leverage AI and robotics for lab automation. This investment could signal further growth in the biotech automation sector.

AI-written summary. May contain errors.

AI Health